Category: image manipulation

President of Taiwan university to step down amidst investigation

Pan-Chyr Yang

The president of a top university in Taiwan has announced he will resign from his post at the end of his first term in June.

President Pan-chyr Yang of National Taiwan University (NTU) has opted not to seek a second term as president given two recent investigations — one which concluded last month and one which is ongoing — into allegations of misconduct in papers he co-authored.

Despite being cleared of misconduct in the investigation conducted by his university, Yang felt that the scandal had left a stain on NTU’s reputation, which he hoped to restore by stepping down as president. Here’s more from Focus Taiwan: Continue reading President of Taiwan university to step down amidst investigation

Two more retractions for stem cell researcher appealing her dismissal

Susana Gonzalez

Susana Gonzalez, a rising star in stem cell research, has had a rough year.

In addition to being fired from her former research institute (which she is now appealing), one of her grants (totaling nearly 2 million Euros) was suspended. Most recently, she has received two new retractions in Nature Communications over figure duplications and missing raw data. By our count, she has a total of three retractions.

Both of the new notices say the papers contained figures duplicated in other papers by Gonzalez, and neither includes Gonzalez among the list of co-authors who agreed to the retraction.

Gonzalez was dismissed from her position at the National Center for Cardiovascular Research (CNIC) in Spain last February over allegations of misconduct. According to the head of basic research at CNIC, Gonzalez is still embroiled in a legal battle with the Center over her dismissal. Vicente Andrés could not go into detail because of the ongoing litigation, but he told us: Continue reading Two more retractions for stem cell researcher appealing her dismissal

Why don’t the raw data match what was reported in a chemistry paper?

Chemistry researchers in China have retracted their 2016 paper after reporting that the raw data did not match what they presented in the article.

The authors were attempting to develop a method to produce large amounts of a high-quality two-dimensional form of antimonene, a prized crystal structure that has been notoriously difficult to synthesize reliably.

They were successful, according to the paper, achieving “a large quantity of few-layer antimonene” and demonstrating its “exact atomical structure” and properties.

But they may have spoken too soon. Continue reading Why don’t the raw data match what was reported in a chemistry paper?

Prominent NIH researcher up to a dozen retractions

Stanley Rapoport. Source: NIH

Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.

Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.

The latest batch of retractions stem from the actions of Jagadeesh Rao.

Here’s the first notice, issued by Psychopharmacology:

Continue reading Prominent NIH researcher up to a dozen retractions

Negligence by stressed-out postdoc led to retraction of high-profile paper, supervisor says

The timing was tight, but Sergio Gonzalez had done it. Gonzalez, a postdoctoral researcher at the Institute for Neurosciences of Montpellier (INSERM) in France, had a paper accepted in a top journal by the end of 2015, just in time to apply for a small number of highly sought-after permanent research positions that open up in France each year.

If Gonzalez had missed the January deadline for this system of advancement, known as concours, he would have had to wait until the following cycle to apply.

Once his paper was accepted by the Journal of Clinical Investigation, Gonzalez could breathe a sigh of relief. He began being invited to interviews. But then, a comment showed up at PubPeer.

Continue reading Negligence by stressed-out postdoc led to retraction of high-profile paper, supervisor says

Huh? Cancer paper gets retracted because of its correction

Here’s a rather odd case: When readers raised issues about some of the images in a 2008 cancer paper, the authors issued a correction last year. But when readers asked additional questions about the corrected images, the authors decided to retract the paper entirely, along with its correction.

Both the original and corrected versions were questioned on PubPeer.

Here’s the retraction notice for the 2008 article “PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2,” published in Oncogene, which includes a link to the July 2016 correction: Continue reading Huh? Cancer paper gets retracted because of its correction

15-year old paper pulled for image problems

A group of researchers in France has been forced to retract their 2002 article in the Journal of Virology after learning that the paper was marred by multiple image problems.

The paper, “P0 of Beet Western Yellows Virus Is a Suppressor of Posttranscriptional Gene Silencing,” came from the lab of Veronique Ziegler-Graff, a plant biologist at the University Louis Pasteur, in Strasbourg. The authors attribute some of the image problems to “genuine mounting mistakes,” and have repeated the experiments to confirm the conclusion, as have other labs. However, the researchers couldn’t find all the original data from the 2002 paper.

Although the retraction statement points the finger at the first author, Sebastien Pfeffer, the list of contributors includes Patrice Dunoyer, a frequent collaborator of Olivier Voinnet, a high-profile plant biologist whose work has come under intense scrutiny.

According to the lengthy notice:
Continue reading 15-year old paper pulled for image problems

Journal flags another paper by diabetes researcher who sued to stop retractions

It would seem that resorting to legal means to avoid editorial notices doesn’t always work.

We’re coming to that conclusion after seeing yet another notice for Mario Saad, based at the University of Campinas in São Paulo, Brazil. In this case, it’s an expression of concern from the Journal of Endocrinology, on a 2005 paper that lists Saad as the second-to-last author. According to the notice, the journal is concerned the paper contains spliced and duplicated images; although the authors offered to repeat the experiments, the journal considered that potential delay “unacceptable.”

Despite Saad’s legal efforts, he is now up to 11 retractions, along with multiple expressions of concern.

Here’s the full text of the notice (which is paywalled, tsk tsk):

Continue reading Journal flags another paper by diabetes researcher who sued to stop retractions

Cancer researcher has dodged accusations for decades (and has a new correction)

Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU).

The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been many more.

The story mentions a 2013 letter from Ohio State University to pseudonymous whistleblower Clare Francis (which we reported on in 2014), acknowledging Francis’s allegations against Croce. However, in the letter, an administrator said OSU saw no reason to investigate Croce.

The story didn’t stop there, as the Times reports:

Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)

3rd retraction appears for fired Pfizer breast cancer researcher

Pfizer has retracted a paper by a former employee who was fired after the company discovered she had been doctoring data.

The retraction, in Molecular Cancer Research, is the third of five papers Pfizer asked to retract, after an investigation discovered they contained duplicated images. The papers have been discussed on PubPeer, which is also mentioned in the latest retraction notice.

As a result of the investigation, Pfizer terminated the employment of Min-Jean Yin, the last author on the newly retracted paper.

According to the notice, Yin and five of her co-authors agreed to the retraction:

Continue reading 3rd retraction appears for fired Pfizer breast cancer researcher